Physician profile
Jaspreet Kaur
NPI 1528749876
$2,295.13
in general payments reported to CMS, 2019-2025
7 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $338 · 2024: $1,691 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,277 · Travel and Lodging: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,277.27 |
| Travel and Lodging | $1,017.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,329.12 | 2024 | |
| Dompe US, INC. | $315.10 | 2023-2024 | Oxervate |
| Bausch & Lomb Americas INC. | $217.30 | 2023 | Infuse, Miebo |
| Amgen INC. | $207.36 | 2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $117.18 | 2024-2025 | |
| Lkc Technologies, INC. | $90.71 | 2024 | |
| Sun Pharmaceutical Industries INC. | $18.36 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaspreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.